Block Chain

Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

Am-DevelAm-Devel
Jan 6, 2026 - 02:12
 0  0
Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
Am-Devel
Am-Devel

Related Posts

What’s Going On With Elon Musk and Ryanair? Here’s What You Need to Know

What’s Going On With Elon Musk and Ryanair? Here’s What...

Am-Devel Jan 23, 2026  0  0

GoMining, Jacob & Co. Debut $40K Luxury Bitcoin Watch Paired With 'Digital Miner'

GoMining, Jacob & Co. Debut $40K Luxury Bitcoin Wat...

Am-Devel Jan 23, 2026  0  0

New Bitcoin Whales Outpace Old Guard in $6B Supply Tug-of-War

New Bitcoin Whales Outpace Old Guard in $6B Supply Tug-...

Am-Devel Jan 23, 2026  0  0

Dogecoin Foundation-Backed 21Shares DOGE ETF Launches on Nasdaq

Dogecoin Foundation-Backed 21Shares DOGE ETF Launches o...

Am-Devel Jan 23, 2026  0  0

Bitcoin Spike to $90K Boosts Crypto Liquidations Above $1 Billion as Trump Dumps Tariffs

Bitcoin Spike to $90K Boosts Crypto Liquidations Above ...

Am-Devel Jan 23, 2026  0  0

Expect AGI Within a Few Years, Says Anthropic CEO—and Job Losses Too

Expect AGI Within a Few Years, Says Anthropic CEO—and J...

Am-Devel Jan 23, 2026  0  0